8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):     June 16, 2005

Lincare Holdings Inc.

(Exact name of registrant as specified in its charter)

Delaware	0-19946	51-0331330
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification Number)

19387 U.S. 19 North, Clearwater, FL 33764

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code:     727-530-7700

(Former name or address, if changed from last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A. 2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01	Regulation FD Disclosure
	On June 16, 2005, Lincare Holdings Inc. issued a press release announcing that John P. Byrnes, Chairman and Chief Executive Officer, has amended his prearranged stock trading plan in accordance with Rule 10b5-1 of the Securities and Exchange Commission. A copy of the press release is attached as Exhibit 99.1.
Item 9.01	Financial Statements and Exhibits
	(c)	Exhibits
	99.1	Press release of Lincare Holdings Inc. dated June 16, 2005.

SIGNATURES

          Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	LINCARE HOLDINGS INC.
	By:	/s/PAUL G. GABOS
		Paul G. Gabos
		Chief Financial Officer, Treasurer and Secretary
June 17, 2005

EX-99.1

Exhibit 99.1

FOR IMMEDIATE RELEASE

Contact:	Investor Relations Department
	(727) 530-7700

LINCARE CEO EXTENDS 10b5-1 STOCK PLAN

Clearwater, Florida (June 16, 2005) - - Lincare Holdings Inc. today announced that John P. Byrnes, chairman and chief executive officer, has amended his prearranged trading plan to extend the term of the plan and to sell additional shares in the company in accordance with Rule 10b5-1 of the Securities and Exchange Commission.

The previously disclosed plan is amended to increase the term of the plan and to add options for approximately 300,000 shares to be exercised and sold pursuant to the plan, subject to the satisfaction of certain price targets for the shares. 

Lincare, headquartered in Clearwater, Florida, is one of the nation’s largest providers of oxygen and other respiratory therapy services to patients in the home.  The Company provides services and equipment to over 560,000 customers in 47 states.

Any statements in this release concerning future results, performance or expectations are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All forward-looking statements included in this document are based upon information available to Lincare as of the date hereof and Lincare assumes no obligation to update any such forward-looking statements.  These statements involve known and unknown risks, uncertainties and other factors that may cause Lincare’s actual results, levels of activity, performance or achievements to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statements.  In some cases, forward-looking statements that involve risks and uncertainties contain terminology such as “may,” “will,” “should,” “could,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or variations of these terms or other comparable terminology.